Mind's Open Up project is proud to be supporting the free One in Four conference 'Talking about mental health - getting it right' - in London on 1 February. One in Four is a national magazine written by people with mental health difficulties. Open Up is supporting them to deliver the conference as part of their Open Up Initiatives Scheme. The conference will look at the ways in which mental health and wellbeing is represented in the media and think about how we can all get better at discussing it. It bring together professionals, people who experience mental health difficulties, and people with a foot in both camps, to set a new agenda for how the media, companies and public bodies talk about mental health.
Scientists have long eyed mutations in a gene known as DISC1 as a possible contributor to schizophrenia and mood disorders, including depression and bipolar disorder. Now, new research led by Johns Hopkins researchers suggests that perturbing this gene during prenatal periods, postnatal periods or both may have different effects in mice, leading to separate types of brain alterations and behaviors with resemblance to schizophrenia or mood disorders. The findings, reported online Jan. 5 in Molecular Psychiatry, could eventually help researchers treat mental illness in people or even prevent it. To manipulate DISC1 expression during different periods, the researchers, led by Associate Professor Mikhail Pletnikov, M.
Research Shows That Weight Loss Products Advertised In Spam E-Mail Are Purchased By Young Adults With Weight Problems: Psychological Stress Implicated
Forty-one percent of college students with weight problems opened and read spam e-mail advertising weight loss products and 18.5 percent bought these weight loss products, according to a new study published in the January issue of the Southern Medical Journal. The research was conducted by Joshua Fogel, Ph.D., an Associate Professor of the Business Program at the Department of Economics at Brooklyn College, and Sam Shlivko, B.S., a former Brooklyn College student and currently a student at New York Law School. In additional analyses considering the impact of a number of relevant variables, those with weight problems as compared to those without weight problems, were three times more likely to open/read and also three times more likely to purchase weight loss products from this spam e-mail.
An increasing number of U.S. adults are being prescribed combinations of antidepressants and antipsychotic medications, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals. In some clinical situations, evidence suggests that more than one psychotropic (affecting the brain or mind) medication may be beneficial, according to background information in the article. For instance, a patient with depression who does not respond to one medication alone might require a second antidepressant, or an individual who has depression with psychotic features might respond to a combination of an antidepressant and an antipsychotic.
Many U.S. adults with major depression do not receive treatment for depression or therapy based on treatment guidelines, and some racial and ethnic groups have even lower rates of adequate depression care, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Depression is a leading cause of disability among many racial and ethnic groups in the United States, according to background information in the article. Pharmacotherapy (including antidepressants) and psychotherapy are both effective, well tolerated treatments for depression when provided according to established guidelines (such as those from the American Psychiatric Association), the authors note.
The National Alliance on Mental Illness (NAMI) praises a new report, Caregiving in the U.S. 2009, which offers a revealing portrait of the nearly one-in-three American adults who serve as a family caregiver. The study is based on interviews with 1, 480 caregivers chosen at random and offers a national profile of people caring for adults, the elderly and children with special needs. It follows similar studies conducted in 2004 and 1997, but for the first time, caregivers for children, as well as those caring for adults over the age of 18, were surveyed. The report echoes the findings of NAMI's own depression survey and schizophrenia survey, which include the perspective of caregivers for people living with these serious mental illnesses.
Pfizer's Lyrica Receives Complete Response Letter From FDA For Generalized Anxiety Disorder Monotherapy Treatment
Pfizer Inc. (NYSE: PFE) announced that the Food and Drug Administration (FDA) issued a Complete Response letter regarding the company's New Drug Application (NDA) for Lyrica ® (pregabalin) capsules CV as a monotherapy treatment for generalized anxiety disorder (GAD). The FDA determined that the data contained in the NDA were insufficient to support approval. The application was a resubmission in response to a "not-approvable" letter issued by the FDA in August 2004. The FDA continues to review a separate application for Lyrica as adjunctive therapy for the treatment of GAD. "We are disappointed with the FDA's decision and will work with the agency to determine next steps" "We are disappointed with the FDA's decision and will work with the agency to determine next steps, " said Steve Romano, vice president, Medical Affairs Head, Primary Care Business Unit.
A new study reports that repeated deployments to Iraq and Afghanistan may adversely affect the mental health of these deployed soldiers. Researchers assessed the effects of prior military service in Iraq or Afghanistan on the health of New Jersey Army National Guard members preparing for deployment to Iraq. They analyzed anonymous, self-administered pre-deployment surveys from 2, 543 National Guard members deployed to Iraq in 2008, measuring for effects on mental or physical health. They found that previously deployed soldiers were more than three times as likely as soldiers with no previous deployments to screen positive for posttraumatic stress disorder and major depression, more than twice as likely to report chronic pain, and more than 90 percent more likely to score below the general population norm on physical functioning.
Marijuana is the most commonly used illicit drug in the United States. Roughly eight to 12 percent of marijuana users are considered "dependent" and, just like alcohol, the severity of symptoms increases with heavier use. A new study has found that use and misuse of alcohol and marijuana are influenced by a common set of genes. Results will be published in the March 2010 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View. "Results from a large annual survey of high-school students show that in 2008, 41.8 percent of 12th graders reported having used marijuana, " explained Carolyn E. Sartor, a research instructor at Washington University School of Medicine and corresponding author for the study.
Students who watch as their peers endure the verbal or physical abuses of another student could become as psychologically distressed, if not more so, by the events than the victims themselves, new research suggests. Bullies and bystanders may also be more likely to take drugs and drink alcohol, according to the findings, which are reported in the December issue of School Psychology Quarterly, published by the American Psychological Association. "It's well documented that children and adolescents who are exposed to violence within their families or outside of school are at a greater risk for mental health problems than those children who are not exposed to any violence, " said the study's lead author, Ian Rivers, PhD.